Massimo Barberi

EMA opens consultation on non-clinical requirements for microbiome-based medicines: what companies should do now

CHMP has announced the development of a dedicated reflection paper on the non-clinical development and evaluation of microbiome-based medicinal products (MMPs).

Probiotics and prevention: the €10 billion question for Europe

New IPA Europe analysis puts hard numbers on how evidence-based probiotic use could cut healthcare costs and boost productivity across the EU.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.